Search research articles
Contact Us
Filters
Showing results (181-190 of 315) with videos related to
Page
of 32
Sort By:
Psychophysiology
|
July 5, 2020
Features of autonomic cardiovascular control during cognition in major depressive disorder
Angela Bair, Josef Marksteiner, Reingard Falch, et al.
Plos One
|
August 26, 2014
Changes in white matter integrity before conversion from mild cognitive impairment to Alzheimer's disease
Michaela Defrancesco, Karl Egger, Josef Marksteiner, et al.
Annals of the New York Academy of Sciences
|
April 24, 1997
Distribution and processing of secretoneurin in the developing rat brain
A Saria, W A Kaufmann, J Marksteiner, et al.
Brain Research. Molecular Brain Research
|
November 1, 1992
Temporal lobe epilepsy of the rat: differential expression of mRNAs of chromogranin B, secretogranin II, synaptin/synaptophysin and p65 in subfield of the hippocampus
S K Mahata, J Marksteiner, G Sperk, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
November 29, 2008
Impairment in emotion recognition abilities in patients with mild cognitive impairment, early and moderate Alzheimer disease compared with healthy comparison subjects
Elisabeth M Weiss, Christian G Kohler, Julia Vonbank, et al.
Frontiers in Aging Neuroscience
|
October 23, 2019
Assessment of Fractal Characteristics of Locomotor Activity of Geriatric In-Patients With Alzheimer's Dementia
Stefan E Huber, Pierre Sachse, Andreas Mauracher, et al.
Brain Research
|
March 3, 2007
Localization and expression of substance P in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations
Michael Willis, Birgit Hutter-Paier, Georg Wietzorrek, et al.
Pharmacology
|
September 24, 2008
Analysis of cerebrospinal fluid of Alzheimer patients. Biomarkers and toxic properties
Josef Marksteiner, Michael Pirchl, Celine Ullrich, et al.
Schizophrenia Research
|
October 5, 2002
Reduction of chromogranin B-like immunoreactivity in distinct subregions of the hippocampus from individuals with schizophrenia
Clara Nowakowski, Walter A Kaufmann, Christine Adlassnig, et al.
Dementia and Geriatric Cognitive Disorders
|
October 26, 2005
Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias
Imrich Blasko, Wolfgang Lederer, Harald Oberbauer, et al.
Page
of 32
Search research articles
Search
Showing results (181-190 of 315) with videos related to
Sort By:
Page
of 32
Psychophysiology
|
July 5, 2020
Features of autonomic cardiovascular control during cognition in major depressive disorder
Angela Bair, Josef Marksteiner, Reingard Falch, et al.
Plos One
|
August 26, 2014
Changes in white matter integrity before conversion from mild cognitive impairment to Alzheimer's disease
Michaela Defrancesco, Karl Egger, Josef Marksteiner, et al.
Annals of the New York Academy of Sciences
|
April 24, 1997
Distribution and processing of secretoneurin in the developing rat brain
A Saria, W A Kaufmann, J Marksteiner, et al.
Brain Research. Molecular Brain Research
|
November 1, 1992
Temporal lobe epilepsy of the rat: differential expression of mRNAs of chromogranin B, secretogranin II, synaptin/synaptophysin and p65 in subfield of the hippocampus
S K Mahata, J Marksteiner, G Sperk, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry
|
November 29, 2008
Impairment in emotion recognition abilities in patients with mild cognitive impairment, early and moderate Alzheimer disease compared with healthy comparison subjects
Elisabeth M Weiss, Christian G Kohler, Julia Vonbank, et al.
Frontiers in Aging Neuroscience
|
October 23, 2019
Assessment of Fractal Characteristics of Locomotor Activity of Geriatric In-Patients With Alzheimer's Dementia
Stefan E Huber, Pierre Sachse, Andreas Mauracher, et al.
Brain Research
|
March 3, 2007
Localization and expression of substance P in transgenic mice overexpressing human APP751 with the London (V717I) and Swedish (K670M/N671L) mutations
Michael Willis, Birgit Hutter-Paier, Georg Wietzorrek, et al.
Pharmacology
|
September 24, 2008
Analysis of cerebrospinal fluid of Alzheimer patients. Biomarkers and toxic properties
Josef Marksteiner, Michael Pirchl, Celine Ullrich, et al.
Schizophrenia Research
|
October 5, 2002
Reduction of chromogranin B-like immunoreactivity in distinct subregions of the hippocampus from individuals with schizophrenia
Clara Nowakowski, Walter A Kaufmann, Christine Adlassnig, et al.
Dementia and Geriatric Cognitive Disorders
|
October 26, 2005
Measurement of thirteen biological markers in CSF of patients with Alzheimer's disease and other dementias
Imrich Blasko, Wolfgang Lederer, Harald Oberbauer, et al.
Page
of 32